Clinical Interpretation of Brain PET Scans: Performing Visual Assessments, Providing Quantifying Data, and Generating Integrated Reports

  • Daniel H.S. Silverman

Visual assessment of brain FDG PET data represents a fundamental skill, independent of the particular clinical indication toward which it is being applied. In our imaging facility, we routinely employ a systematic approach for evaluating regional metabolism throughout the brain. In addition, beginning in 2004, software tools approved by the Food and Drug Administration for quantifying relative regional activity became available to assist with that evaluation. This chapter first describes key aspects of a skilled visual assessment, and then examines methods of regional quantification that are practical in typical clinical environments, and, finally, illustrates an approach toward scan interpretation that integrates the visual and quantifying information present in clinical PET scans.


Posterior Cingulate Cortex Interhemispheric Fissure Average Cortex Generalize Atrophy Cortical Hypometabolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    1. Buchert R, Santer R, Brenner W, et al. Computer simulations suggest that acute correction of hyperglycemia with an insulin bolus protocol might be useful in brain FDG PET. Nuklearmedizin 2009:(in press).Google Scholar
  2. 2.
    2. Minoshima S, Frey KA, Burdette JH, Interpretation of metabolic abnormalities in Alzheimer’s disease using three-dimensional stereotactic surface projections (3D-SSP) and normal database. J Nucl Med 1995;36:237P.Google Scholar
  3. 3.
    3. Moeller JR, Ishikawa T, Dhawan V. The metabolic topography of normal aging. J Cereb Blood Flow Metab 1996;16:385–398.PubMedCrossRefGoogle Scholar
  4. 4.
    4. Ishii K, Sakamoto S, Sasaki M. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 1998;39:1875–1878.PubMedGoogle Scholar
  5. 5.
    5. Silverman DHS, Alavi A. PET imaging in the assessment of normal and impaired cognitive function. Radiol Clin North Am 2005;43:67–77.PubMedCrossRefGoogle Scholar
  6. 6.
    6. Minoshima S, Giordani B, Berent S. Metabolic reduction in the posterior cingulate cortex in very early AD. Ann Neurol 1997;42:85–94.PubMedCrossRefGoogle Scholar
  7. 7.
    7. Silverman DHS. Brain F-18-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J Nucl Med 2004;45:594–607.PubMedGoogle Scholar
  8. 8.
    Silverman DHS, Small GW, Chang CY et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and longterm outcome. JAMA 2001;286:2120–2127.PubMedCrossRefGoogle Scholar
  9. 9.
    Silverman DH, Truong CT, Kim SK, et al. Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. Mol Genet Metab 2003;80:350–355.PubMedCrossRefGoogle Scholar
  10. 10.
    Silverman DH, Mosconi L, Ercoli L, et al. Positron emission tomography scans obtained for the evaluation of cognitive dysfunction. Semin Nucl Med 2008;38:251–61.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  • Daniel H.S. Silverman
    • 1
  1. 1.Division of Biological Imaging; Department of Molecular and Medical PharmacologyUCLA Alzheimer’s Disease Center Imaging Core, David Geffen School of Medicine, University of CaliforniaLos AngelesCA

Personalised recommendations